Gyno-Femidazol (Miconazole Nitrate)

Gyno-Femidazol is indicated for the treatment of fungal infections affecting the female genital tract. It is commonly prescribed for:

• Management of vulvovaginal candidiasis caused by Candida species
• Relief of itching, burning, and abnormal discharge associated with yeast infections
• Prevention of recurrence after successful therapy
• Use as part of a comprehensive treatment plan for symptomatic vaginal yeast infections
• Adjunct therapy when topical antifungal treatment is preferred over oral agents

Side effects of Gyno-Femidazol are generally mild and localized, but serious reactions can occur in rare cases.

Common

• Vaginal irritation or burning sensation
• Itching or mild discomfort at the application site
• Unpleasant vaginal odor
• Discharge that may be watery or milky
• Mild abdominal cramps
• Headache (occasionally reported)

Serious

• Severe allergic reaction (rash, swelling, difficulty breathing)
• Persistent or worsening vaginal irritation
• Signs of secondary bacterial infection (fever, foul odor)
• Unusual vaginal bleeding
• Swelling of the vulvar area

Before using Gyno-Femidazol, consider the following precautions to ensure safe and effective treatment:

• Confirm the diagnosis of a fungal infection; avoid use for bacterial or viral vaginitis.
• Discuss any known allergies to azole antifungals or miconazole.
• Inform a healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
• Avoid concurrent use of intravaginal products (e.g., douches, spermicides) that may interfere with absorption.
• Report any persistent irritation, rash, or systemic symptoms promptly.
• Use the product exactly as directed; do not exceed the recommended duration of therapy.
• Seek medical advice if symptoms do not improve within the expected timeframe.

Gyno-Femidazol may interact with other medications or substances when used vaginally. Consider the following interaction guidance:

Avoid

• Concurrent use of systemic azole antifungals (e.g., fluconazole) without medical supervision, as additive toxicity may occur.
• Insertion of vaginal contraceptive devices (e.g., diaphragms) during treatment, which can reduce efficacy.

Use with caution

• Topical estrogen creams, which may alter vaginal flora and affect drug absorption.
• Antifungal shampoos or creams applied to nearby skin areas.
• Systemic medications metabolized by cytochrome P450 enzymes; discuss with a clinician if you are on such drugs.
• Over‑the‑counter vaginal moisturizers or lubricants; ensure they do not contain irritants.